Skip to main content

Hyperlactatemia in critical illness and cardiac surgery

We read with interest the article by Nichol and colleagues [1] in a recent issue of Critical Care. Their study of more than 7,000 medical and surgical patients supports the claim that an admission plasma lactate level in the upper normal range is associated with increased mortality. However, we are concerned about the lack of data regarding patient baseline characteristics. Specifically, although 3,166 and 1,614 patients had diagnoses of 'surgery' and 'cardiac/vascular', respectively, it is likely, but not stated, that numerous patients were admitted following cardiac surgery. This is of great importance as changes in lactate in this patient group are not homogenous in nature.

In post-cardiac surgery patients, early hyperlactatemia and late hyperlactatemia (LHL) differ in both risk profile and physiological rationale. Early hyperlactatemia (on intensive care unit arrival) is associated with adverse outcome. This association is not seen in the 10% to 20% of patients who develop LHL (pooled odds ratio [OR] of death with LHL in two published trials 1.39, 95% confidence interval [CI] 0.28 to 7.04) [24]. Moreover, in our recent single-center review of prospectively collated data from 529 post-cardiac surgical patients in a tertiary Australian cardiac surgical intensive care unit, 25% developed LHL (>2.53 mmol/L). When compared with patients with a normal lactate profile, patients with LHL showed no increase in hospital mortality (OR 0.57, 95% CI 0.07 to 5.05) (unpublished data).

Therefore, we believe that inclusion of such patients in studies of lactate in critical illness should be avoided and, as in the study by Nichol and colleagues, may actually weaken any association demonstrated between lactate levels and hospital mortality.

Authors' response

Alistair D Nichol, Michael Bailey and Rinaldo Bellomo

We thank O'Connor and Fraser for their comments, which suggest a differing association between early and late hyperlactatemia and mortality in post-operative cardiac surgery patients and that the inclusion of this cohort in our 'cardiac/vascular' group may have weakened the association between lactate and mortality in our study.

They are correct in assuming that a significant number of patients from the 'cardiac/vascular' group were postoperative cardiac patients, as three of the four intensive care units in our study support busy cardiothoracic services. Unfortunately, the coding of our database prevents us from identifying these patients in more detail. However, we were able to separate and examine the cardiac/vascular group, the surgical group, and the cardiac/vascular patients who underwent surgery. In the cardiac/vascular surgical group, the risk of death was increased with hyperlactatemia compared with all of the other groups (Table 1). In addition, the risk of death determined by maximal and time-weighted lactate (more strongly reflecting post-admission lactate levels) was greater in the cardiac/vascular surgical group compared with the other groups (Table 1).

Table 1 Odds ratios of mortality for a 1-unit increase in lactate, adjusting for gender, age, APACHE II, mechanical ventilation, and diagnosis type considering the full dataset and three subgroups

These findings demonstrate that early (admission) and late (post-admission) hyperlactatemia are both strongly associated with mortality in cardiac/vascular surgical patients (of whom a significant number were postoperative cardiac patients). This would suggest that the inclusion of cardiac surgical patients did not weaken the association with mortality; it actually strengthened the overall association. These findings demand more study of lactate in the cardiac surgical cohort, and we eagerly await the publication of the results alluded to by O'Connor and Fraser.

Abbreviations

CI:

confidence interval

LHL:

late hyperlactatemia

OR:

odds ratio.

References

  1. 1.

    Nichol AD, Egi M, Pettila V, Bellomo R, French C, Hart G, Davies A, Stachowski E, Reade MC, Bailey M, Cooper DJ: Relative hyperlactatemia and hospital mortality in critically ill patients: a retrospective multi-centre study. Crit Care 2010, 14: R25. 10.1186/cc8888

    PubMed Central  Article  PubMed  Google Scholar 

  2. 2.

    Totaro RJ, Raper RF: Epinephrine-induced lactic acidosis following cardiopulmonary bypass. Crit Care Med 1997, 25: 1693-1699. 10.1097/00003246-199710000-00019

    CAS  Article  PubMed  Google Scholar 

  3. 3.

    Raper RF, Cameron G, Walker D, Bowey CJ: Type B lactic acidosis following cardiopulmonary bypass. Crit Care Med 1997, 25: 46-51. 10.1097/00003246-199701000-00011

    CAS  Article  PubMed  Google Scholar 

  4. 4.

    Maillet JM, Le Besnerais P, Cantoni M, Nataf P, Ruffenach A, Lessana A, Brodaty D: Frequency, risk factors, and outcome of hyperlactatemia after cardiac surgery. Chest 2003, 123: 1361-1366. 10.1378/chest.123.5.1361

    Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Enda D O'Connor.

Additional information

Competing interests

The authors declare that they have no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

O'Connor, E.D., Fraser, J.F. Hyperlactatemia in critical illness and cardiac surgery. Crit Care 14, 421 (2010). https://doi.org/10.1186/cc9017

Download citation

Keywords

  • Hospital Mortality
  • Critical Illness
  • Lactate Level
  • Pool Odds Ratio
  • Plasma Lactate Level